Pharmena S.A. (WSE:PHR)

Poland flag Poland · Delayed Price · Currency is PLN
3.340
+0.040 (1.21%)
Feb 24, 2026, 5:03 PM CET
Market Cap36.75M -29.6%
Revenue (ttm)1.27M +313.6%
Net Income-2.20M
EPS-0.20
Shares Out11.14M
PE Ration/a
Forward PEn/a
Dividend0.85 (25.76%)
Ex-Dividend Daten/a
Volume3,422
Average Volume5,361
Open3.420
Previous Close3.300
Day's Range3.300 - 3.420
52-Week Range2.500 - 4.700
Beta0.79
RSI46.08
Earnings DateFeb 23, 2026

About Pharmena

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PHR
Full Company Profile

Financial Performance

Financial Statements